Last reviewed · How we verify

Dehydroepiandrosterone (DHEAS)

Taipei Veterans General Hospital, Taiwan · Phase 3 active Small molecule

DHEA-S is an endogenous steroid hormone precursor that acts as a substrate for sex hormone synthesis and modulates immune and metabolic function.

DHEA-S is an endogenous steroid hormone precursor that acts as a substrate for sex hormone synthesis and modulates immune and metabolic function. Used for Age-related decline in DHEA-S levels (Phase 3), Systemic lupus erythematosus (SLE) or autoimmune conditions (investigational).

At a glance

Generic nameDehydroepiandrosterone (DHEAS)
Also known asDHEAS
SponsorTaipei Veterans General Hospital, Taiwan
Drug classEndogenous steroid hormone / Adrenal hormone replacement
TargetAndrogen receptor, Estrogen receptor (indirect via peripheral conversion)
ModalitySmall molecule
Therapeutic areaEndocrinology / Immunology / Aging
PhasePhase 3

Mechanism of action

Dehydroepiandrosterone sulfate (DHEA-S) is a weak androgen and estrogen precursor produced primarily by the adrenal glands. It serves as a substrate for the synthesis of testosterone and estrogen in peripheral tissues, and also exerts direct effects on immune cell function, bone metabolism, and metabolic homeostasis through both classical steroid receptor pathways and non-genomic signaling mechanisms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results